37 posts on this topic, sorted most recent first.
Three drugs are about to change the GLP-1 conversation again. Orforglipron just got FDA approval. CagriSema is in phase 3 readouts. MariTide is the longer-tail bet. Here's the honest read on which deserves your patience and which is hype.
We've been running the same 11-signal rubric against every GLP-1 telehealth and pharmacy operator we could find. 77 vendors across 19 regions, scored on the same axes. The pattern that emerged was not what we expected.
Bangkok is the lowest-friction GLP-1 access point in Asia for English-speaking adults. Here's the complete map: which clinics actually fill scripts for foreigners, what they charge, what to bring, what to expect.
The UAE GLP-1 market splits between Dubai's larger and more expat-oriented private clinic ecosystem and Abu Dhabi's more institutionally-driven hospital network. Both work. The right choice depends on your insurance, residence, and what you're actually trying to achieve.
The most-quoted patient experience on tirzepatide is that the food noise stops. Here's what people mean by it, what's actually happening neurologically, and why it doesn't return for everyone after stopping.
The mental health conversation around GLP-1s has gotten louder in the last year. Some of the signal is real and worth taking seriously. Some is noise. Here's the honest separation.
The London private GLP-1 market has fragmented since the NHS Wegovy expansion in late 2025. Here's the current operational state of who's prescribing, what they charge, and which path is wrong for whom.
Singapore is more expensive but more predictable. Bangkok is cheaper but more variable. The right choice depends on your trip length, risk tolerance, and whether you're optimizing for a single visit or a relationship.
Sleep changes on tirzepatide are real and patterned. Some are good (apnea improvement is well-documented), some are mixed (lighter sleep early on), some are bad if you ignore them. Here's the full picture.
The most common reader question I get from people who train regularly is whether tirzepatide will tank their lifts. The honest answer is more interesting than yes or no.
Microdosing GLP-1 went from a fringe biohacker idea to a question people ask their doctor. The clinical data is thinner than the discourse suggests, but it's not nothing. Here's what's known.
The mistake most people make on the switch is treating it like upgrading a phone. The drugs work on different receptor mixes and the body needs a beat to recalibrate. Here's how to do it without the rebound.
BPOM intermittency means the existing Bali buyers guide gets stale fast. This is the May 2026 supply-state tactical · per-clinic Mounjaro and Ozempic stocking, the most-current expat-routable picks, and the Bangkok-hop fallback when the nomad-clinic layer has gaps.
Bangkok is the regional anchor for legitimately-supplied tirzepatide and semaglutide in Southeast Asia. Flight matrices, clinic-relationship cadence, cold-chain transit, customs personal-use rules per origin country, and the four-versus-twelve-week supply math.
Weekly read on what's actually in stock at the Bangkok premium hospitals and mid-tier clinics, with price changes since last digest, regulatory movements that affect supply, and the picking question for this week. New format, weekly cadence, BKK-anchored. Issue 1.
The semaglutide and tirzepatide effect on alcohol intake is real and well-documented. The mechanism is partly understood, the long-term safety data is thin, and the practical advice for users on the drug is more nuanced than 'one drink is fine.' What the 2026 SURMOUNT-OASIS and downstream trials add.
HK Department of Health licenses Wegovy + Mounjaro for limited indications. Private clinic supply is steady but premium-priced. The 1h45 Bangkok flight is the cost-arbitrage many HK-resident expats end up using. What's actually licensed, per-clinic pricing, and the picking framework.
The Singapore GLP-1 clinic layer beyond the existing buyers guide. Per-clinic pricing for the four most-routable Singapore providers, MOH-licensed-product reality, the Wegovy-vs-Ozempic supply picture, and when the 2h20 Bangkok flight beats the local cost.
The four most-routable Vietnam clinics for GLP-1 prescribing scored against the 11-signal rubric. FV Hospital (HCMC), Family Medical Practice (HCMC + Hanoi), Raffles Medical (HCMC), Vinmec (multi-city). Saxenda pricing, MoH posture, and the Bangkok-hop framing for the gap.
Side-by-side comparison of the three branded GLP-1 pens available in Bangkok in May 2026. Per-month USD pricing at premium hospitals and mid-tier clinics, supply state per medication, and the picking question once cost is on the table.
The four Bangkok premium hospitals scored on Panya's 11-signal rubric: Bumrungrad, Samitivej Sukhumvit, BNH, and BDMS Wellness Clinic. JCI accreditation, real GLP-1 menu depth, BDMS-group concentration, and how Thailand-resident expats actually pick.
BIMC Hospital, Body Tonic Clinic, Cocoon Medical Spa, Siloam, Kasih Ibu. USD pricing, BPOM posture post-2025 import tightening, and how nomads + expats actually pick a Bali GLP-1 provider.
Chi Longevity, The Longevity GP, Siena Health, Noah, Ordinary Folk, Clifford Clinic. SGD pricing, MOH 87/2024 in-person-first rule, what the 11-signal rubric scores them on, and how expats actually pick.
Metabolic.Health, Endocare, Zone.Health, DarDoc, Valeo, Limitless Human, Hortman, Novomed. AED pricing, DHA / DOH posture, Foundayo arrival, and how to pick the right Emirates GLP-1 route.
Numan, Voy, Juniper, Boots, Asda, Pharmacy2U, ZAVA, Second Nature. Per-dose pricing, MHRA posture, what the rubric scores them on, and how to pick the right one for your situation.
FV Hospital, Family Medical Practice, Raffles Medical, Vinmec. USD pricing, MoH posture, supply intermittency reality, and how expats actually pick a Vietnam GLP-1 provider.
Longevity clinics are prescribing tirzepatide and semaglutide at fractional doses for non-obese patients. Here is what the data supports, what it does not, and the risk-benefit tradeoff.
Retatrutide hits three receptors instead of two. Phase 2 showed 24% weight loss. Phase 3 results expected late 2026. What it is, how it differs from tirzepatide, and why the molecule matters.
The three GLP-1 drugs that matter in 2026: semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and retatrutide (Lilly's triple-agonist). How they differ in mechanism, weight loss, side effects, and cost.
The SURMOUNT-4 trial tracked what happens when people stop tirzepatide after initial weight loss. Here is the honest version of the regain curve, what drives it, and how to think about maintenance.
GLP-1 drugs including tirzepatide reduce alcohol consumption for many users. Here is the mechanism, the observational data, the clinical caution, and how Panya routes patients who mention drinking on intake.
The week-by-week tirzepatide dose schedule from 2.5 mg to 15 mg, why the ramp exists, what clinics skip, and when to plateau. SURMOUNT-1-aligned, clinician-reviewed.
The credentialed clinicians have covered GLP-1 drugs for years. Here is what they actually say, not the clickbait version.
Heat degrades peptides. But not all peptides, not at all temperatures, not at all durations. The honest version of the cold-chain question.
What actually happens when you start tirzepatide. What is common, what is rare, what is serious, what to do about each.
What tirzepatide is, what it costs in Bangkok, how to tell a real clinic from a mediocre one, and the questions you should ask before your first injection.
Same drug class, different receptor profile. Here is the honest comparison, without the marketing gloss.